Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
0.2551 x 1 0.2929 x 10
Pre-market by (Cboe BZX)
0.2705 -0.0135 (-4.75%) 03/27/25 [NASDAQ]
0.2551 x 1 0.2929 x 10
Pre-market 0.2651 -0.0054 (-2.00%) 04:53 ET
Quote Overview for Thu, Mar 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.2527
Day High
0.2950
Open 0.2755
Previous Close 0.2840 0.2840
Volume 174,800 174,800
Avg Vol 408,805 408,805
Stochastic %K 14.87% 14.87%
Weighted Alpha -83.79 -83.79
5-Day Change -0.0100 (-3.57%) -0.0100 (-3.57%)
52-Week Range 0.2505 - 3.1626 0.2505 - 3.1626
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,216
  • Shares Outstanding, K 15,585
  • Annual Sales, $ 2,530 K
  • Annual Income, $ -7,940 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 3.12
  • Price/Sales 0.31
  • Price/Cash Flow N/A
  • Price/Book 1.24
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.82
  • Most Recent Earnings $-0.16 on 11/14/24
  • Next Earnings Date 04/07/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2505 +7.98%
on 03/19/25
Period Open: 0.5224
0.5596 -51.66%
on 02/28/25
-0.2519 (-48.22%)
since 02/27/25
3-Month
0.2505 +7.98%
on 03/19/25
Period Open: 0.8898
1.0099 -73.22%
on 01/07/25
-0.6193 (-69.60%)
since 12/27/24
52-Week
0.2505 +7.98%
on 03/19/25
Period Open: 2.0800
3.1626 -91.45%
on 04/22/24
-1.8095 (-87.00%)
since 03/27/24

Most Recent Stories

More News
Zacks Initiates Coverage of bioAffinity With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of bioAffinity Technologies, Inc. BIAF, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook...

BIAF : 0.2705 (-4.75%)
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END

TRIB : 0.6675 (+4.30%)
BIAF : 0.2705 (-4.75%)
INBS : 1.5600 (-6.59%)
CDIO : 0.4132 (-3.37%)
SOBR : 0.5175 (-7.59%)
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / January 10, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks,...

ENLV : 1.0100 (-3.81%)
BIAF : 0.2705 (-4.75%)
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael...

BIAF : 0.2705 (-4.75%)
BIAFW : 0.2201 (-17.87%)
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will present at the Cleveland...

BIAF : 0.2705 (-4.75%)
BIAFW : 0.2201 (-17.87%)
bioAffinity Technologies to Ring Nasdaq Closing Bell Today

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will ring the Nasdaq Stock...

BIAF : 0.2705 (-4.75%)
NDAQ : 76.36 (-1.51%)
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported...

BIAF : 0.2705 (-4.75%)
BIAFW : 0.2201 (-17.87%)
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed...

BIAF : 0.2705 (-4.75%)
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

bioAffinity Technologies , Inc. (NASDAQ: BIAF; BIAFW) today announced it will report financial results for the three months ended December 31, 2022, on Friday, March 31, 2023, after the market close....

BIAF : 0.2705 (-4.75%)
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) today announced its commercialization team, including the addition of Julie Anne Overton, a veteran of print and broadcast journalism, corporate communications...

BIAF : 0.2705 (-4.75%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 0.3351
2nd Resistance Point 0.3150
1st Resistance Point 0.2928
Last Price 0.2705
1st Support Level 0.2505
2nd Support Level 0.2304
3rd Support Level 0.2082

See More

52-Week High 3.1626
Fibonacci 61.8% 2.0502
Fibonacci 50% 1.7066
Fibonacci 38.2% 1.3629
Last Price 0.2705
52-Week Low 0.2505

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies